Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-040615
Filing Date
2012-07-23
Accepted
2012-07-23 18:42:05
Documents
1
Period of Report
2012-07-19

Document Format Files

Seq Description Document Type Size
1 form324681_20120723064148-.html 3  
1 form324681_20120723064148-.xml 3 5874
  Complete submission text file 0001144204-12-040615.txt   7550
Mailing Address 2910 SEVENTH ST BERKLEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 667 MADISON AVE. 21ST FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE. 21ST FLOOR NEW YORK NY 10065 212-339-5600
14159, L.P. (Reporting) CIK: 0001551138 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 12975312